Lucy To
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Lucy To currently works at SAB Biotherapeutics, Inc., as Chief Financial Officer & Executive Vice President from 2024.
Ms. To also formerly worked at Wells Fargo & Co., as MD-Investment Banking Healthcare Group from 2020 to 2024.
Ms. To received her undergraduate degree from Southern Methodist University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Directeur Financier/CFO | 12/08/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| WELLS FARGO & COMPANY | Corporate Officer/Principal | 01/06/2024 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Wells Fargo & Co.
Wells Fargo & Co. Major BanksFinance Operates as a bank holding company whose subsidiaries provides consumer, commercial, corporate, investment banking and wealth management services | Finance |
Southern Methodist University
Southern Methodist University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAB Biotherapeutics, Inc.
SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national